Thompson Siegel & Walmsley LLC / JAZZ
Thompson Siegel & Walmsley LLC’s Jazz Pharmaceuticals PLC Position
Does Thompson Siegel & Walmsley LLC own Jazz Pharmaceuticals PLC (JAZZ)? Yes — 233.7K shares worth $44M (+0.77% of its 13F portfolio) as of Q1 2026, down from 290.2K shares the prior filed quarter.
Position Value
$44M
Q1 2026
Shares
233.7K
% of Portfolio
+0.77%
Quarters Held
25
currently held
Position History JAZZ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 233.7K | $44M | +0.77% |
| Q4 2025 | 290.2K | $49M | +0.83% |
| Q3 2025 | 373.9K | $49M | +0.80% |
| Q2 2025 | 574.8K | $61M | +1.01% |
| Q1 2025 | 570.8K | $71M | +1.19% |
| Q4 2024 | 700.9K | $86M | +1.34% |
| Q3 2024 | 781.2K | $87M | +1.30% |
| Q2 2024 | 721.5K | $77M | +1.23% |
| Q1 2024 | 552.6K | $67M | +1.02% |
| Q4 2023 | 352.6K | $43M | +0.70% |
| Q3 2023 | 270.6K | $35M | +0.58% |
| Q2 2023 | 78.9K | $10M | +0.16% |
| Q1 2023 | 307 | $45,000 | 0.00% |
| Q4 2022 | 307 | $49,000 | 0.00% |
| Q3 2022 | 307 | $41,000 | 0.00% |
| Q2 2022 | 307 | $48,000 | 0.00% |
| Q1 2022 | 307 | $48,000 | 0.00% |
| Q4 2021 | 455 | $58,000 | 0.00% |
| Q3 2021 | 467 | $61,000 | 0.00% |
| Q2 2021 | 480 | $85,000 | 0.00% |
| Q1 2021 | 375 | $62,000 | 0.00% |
| Q4 2020 | 249.3K | $41M | +0.66% |
| Q3 2020 | 232.3K | $33M | +0.64% |
| Q2 2020 | 328.5K | $36M | +0.73% |
| Q4 2019 | 5 | $1,000 | 0.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Thompson Siegel & Walmsley LLC’s full portfolio or all institutional holders of JAZZ.